Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The aims of the present study were to identify histopathological parameters which are linked to local clinical skin disease at two distinct anatomical sites in systemic sclerosis (SSc) patients with skin involvement (limited cutaneous systemic sclerosis (lcSSc) or diffuse cutaneous systemic sclerosis (dcSSc)) and to determine the sensitivity of SSc specific histological alterations, focusing on SSc patients without clinical skin involvement (limited SSc (lSSc)). METHODS: Histopathological alterations were systematically scored in skin biopsies of 53 consecutive SSc patients (dorsal forearm and upper inner arm) and 18 controls (upper inner arm). Clinical skin involvement was evaluated using the modified Rodnan skin score. In patients with lcSSc or dcSSc, associations of histopathological parameters with local clinical skin involvement were determined by generalised estimation equation modelling. RESULTS: The hyalinised collagen score, the myofibroblast score, the mean epidermal thickness, the mononuclear cellular infiltration and the frequency of focal exocytosis differed significantly between biopsies with and without local clinical skin involvement. Except for mononuclear cellular infiltration, all of the continuous parameters correlated with the local clinical skin score at the dorsal forearm. Parakeratosis, myofibroblasts and intima proliferation were present in a minority of the SSc biopsies, but not in controls. No differences were found between lSSc and controls. CONCLUSIONS: Several histopathological parameters are linked to local clinical skin disease. SSc-specific histological alterations have a low diagnostic sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In skin, the presence of myofibroblasts correlates with the amount of (hyalinized) collagen and skin parameters related to fibrosis such as tightness, hardness and stiffness, and does so more significantly than inflammation (21–23), supporting for a role of myofibroblasts in the pathogenesis of these clinical signs.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Fitzpatrick’s Dermatology in General Medicine
(1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70018-x · Cited by 3,233
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Fitzpatrick’s Dermatology in General Medicine
Dunnick, C. A. (2008) · JAMA · doi:10.1001/jama.299.10.1195-b · Cited by 1,162
Koenig, M., Joyal, F., Fritzler, M. J., Roussin, A., Abrahamowicz, M., Boire, G., Goulet, J., Rich, É., Grodzicky, T., Raymond, Y., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24038 · Cited by 615 · cited 1×
“This subset is considered to have ‘early’ SSc, as a longitudinal follow-up study has demonstrated that these patients are at risk for progression to definite SSc [ 4 ].”
BackgroundClements, P., Lachenbruch, P. A., Seibold, J. R., Zee, B. C.-Y., Steen, V. D., Brennan, P., Silman, A. J., Allegar, N. E., Varga, J., & Massa, M. C. (1993) · PubMed · Cited by 449
Sequential dermal microvascular and perivascular changes in the development of scleroderma
Prescott, R. J., Freemont, A. J., Jones, C. J. P., Hoyland, J., & Fielding, P. (1992) · The Journal of Pathology · doi:10.1002/path.1711660307 · Cited by 391 · cited 1×
“Studies of SSc skin histopathology have described alterations in different skin compartments, including atrophy and increased pigmentation of the epidermis [11], loss of the epidermal papillae [11], increase of melanophages (’pigment incontinence’) [11], the presence of a mononuclear perivascular infiltrate and myofib…”
BackgroundLymphocytes in the skin of patients with progressive systemic sclerosis
Roumm, A. D., Whiteside, T. L., Medsger, T. A., & Rodnan, G. P. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270607 · Cited by 383
Nash, R. A., McSweeney, P. A., Crofford, L. J., Abidi, M., Chen, C.-S., Godwin, J. D., Gooley, T. A., Holmberg, L., Henstorf, G., LeMaistre, C. F., et al. (2007) · Blood · doi:10.1182/blood-2007-02-072389 · Cited by 265 · cited 1×
“The histopathology of SSc skin has recently regained interest because it may be integrated as an outcome measure in clinical trials on skin disease, whereby skin biopsies are obtained before and after administration of a therapeutic drug [5,6].”
Background
Cited by
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis
Jerjen, R., Nikpour, M., Krieg, T. M., Denton, C. P., & Saracino, A. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.10.065 · Cited by 160
Mathian, A., Parizot, C., Dorgham, K., Trad, S., Arnaud, L., Larsen, M., Miyara, M., Hié, M., Pietté, J. C., Francès, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200709 · Cited by 102
Smith, V. M., Piette, Y., Praet, J. T. V., Decuman, S., Deschepper, E., Elewaut, D. S., & Keyser, F. D. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.120778 · Cited by 103
Self-citationNikitorowicz-Buniak, J., Shiwen, X., Denton, C. P., Abraham, D., & Stratton, R. J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.253 · Cited by 90
Metadata
- Authors
- Van Praet, J. T., Smith, V., Haspeslagh, M., Degryse, N., Elewaut, D., & De Keyser, F.
- Affiliations
- Ghent University Hospital (BE)
- Venue
- Arthritis Research & Therapy
- Published
- 2011-02
- Volume
- 13
- Issue
- 1
- Pages
- R35-R35
- ISSN
- 1478-6354 (ISSN-L)
- 1478-6362
- PMC
- PMC3241379
- OpenAlex
- W2137504948
- Cited by
- 47
- References
- 25
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 7 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 1 · 2018: 3 · 2017: 2 · 2015: 2 · 2014: 1 · 2012: 3
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Funders
- Vlaamse regering
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Keywords
- systemic sclerosis, skin involvement, limited cutaneous systemic sclerosis, diffuse cutaneous systemic sclerosis, skin histopathology, myofibroblasts, epidermal thickness, parakeratosis, intimal proliferation, modified Rodnan skin score, diagnostic sensitivity
- MeSH terms
- Adult, Biopsy, Female, Humans, Immunohistochemistry, Male, Middle Aged, Scleroderma, Systemic, Skin, Scleroderma, Limited
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.